Skip to main content

Research Repository

Advanced Search

Current status of drug screening and disease modelling in human pluripotent stem cells

Rajamohan, Divya; Matsa, Elena; Kalra, Spandan; Crutchley, James; Patel, Asha; George, Vinoj; Denning, Chris

Authors

Divya Rajamohan

Elena Matsa

Spandan Kalra

James Crutchley

Asha Patel

Vinoj George

CHRIS DENNING chris.denning@nottingham.ac.uk
Professor of Stem Cell Biology



Abstract

The emphasis in human pluripotent stem cell (hPSC) technologies has shifted from cell therapy to in vitro disease modelling and drug screening. This review examines why this shift has occurred, and how current technological limitations might be overcome to fully realise the potential of hPSCs. Details are provided for all disease-specific human induced pluripotent stem cell lines spanning a dozen dysfunctional organ systems. Phenotype and pharmacology have been examined in only 17 of 63 lines, primarily those that model neurological and cardiac conditions. Drug screening is most advanced in hPSC-cardiomyocytes. Responses for almost 60 agents include examples of how careful tests in hPSC-cardiomyocytes have improved on existing in vitro assays, and how these cells have been integrated into high throughput imaging and electrophysiology industrial platforms. Such successes will provide an incentive to overcome bottlenecks in hPSC technology such as improving cell maturity and industrial scalability whilst reducing cost.

Citation

Rajamohan, D., Matsa, E., Kalra, S., Crutchley, J., Patel, A., George, V., & Denning, C. (2013). Current status of drug screening and disease modelling in human pluripotent stem cells. BioEssays, 35(3), https://doi.org/10.1002/bies.201200053

Journal Article Type Article
Publication Date Mar 1, 2013
Deposit Date Apr 15, 2014
Publicly Available Date Apr 15, 2014
Journal BioEssays
Print ISSN 0265-9247
Electronic ISSN 0265-9247
Publisher Wiley
Peer Reviewed Peer Reviewed
Volume 35
Issue 3
DOI https://doi.org/10.1002/bies.201200053
Keywords Automation, Cardiomyocytes, Drug safety assessment, Human embryonic stem cells, Human induced pluripotent stem cells
Public URL https://nottingham-repository.worktribe.com/output/1002711
Publisher URL http://onlinelibrary.wiley.com/doi/10.1002/bies.201200053/abstract

Files





You might also like



Downloadable Citations